文献速递流行病学与生物统计

随机对照试验研究中基于模型的条件功效评估用于决策

A model-based conditional power assessment for decision making in randomized controlled trial studies.
PubMed 文献 · Stat Med · 2017-09-04

本文在传统基于汇总统计量的条件功效基础上,提出一种基于回归模型的条件功效评估策略,建立了观察到的期中数据与最终未观察数据间参数估计的渐近关系,适用于高斯与非高斯数据。模拟研究表明该方法在处理基线协变量、检测治疗效应及特定缺失机制下控制总体I类错误方面具有优势,并应用于一项临床研究。

要点

  • 提出基于回归模型的条件功效评估,扩展传统汇总统计量方法。
  • 建立期中与最终数据参数估计的渐近关系,适用于高斯与非高斯数据。
  • 模拟研究显示该方法在检测治疗效应和控制I类错误方面有优势。

核心结论

  • 基于模型的条件功效评估策略在检测治疗效应和控制总体I类错误方面较传统方法更具优势。

研究设计与样本

  • 方法学研究,通过广泛模拟研究评估所提方法性能,并应用于一项临床研究。

主要发现

  • 基于模型的条件功效评估可灵活处理基线协变量,且较传统方法在检测治疗效应方面更有效。
  • 在特定缺失数据机制下,基于模型的方法在控制总体I类错误方面更稳健。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Conditional power based on summary statistic by comparing outcomes (such as the sample mean) directly between 2 groups is a convenient tool for decision making in randomized controlled trial studies. In this paper, we extend the traditional summary statistic-based conditional power with a general model-based assessment strategy, where the test statistic is based on a regression model. Asymptotic relationships between parameter estimates based on the observed interim data and final unobserved data are established, from which we develop an analytic model-based conditional power assessment for both Gaussian and non-Gaussian data. The model-based strategy is not only flexible in handling baseline covariates and more powerful in detecting the treatment effects compared with the conventional method but also more robust in controlling the overall type I error under certain missing data mechanisms. The performance of the proposed method is evaluated by extensive simulation studies and illustrated with an application to a clinical study.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Zou B, Cai J, Koch GG, et al. A model-based conditional power assessment for decision making in randomized controlled trial studies. Stat Med. 2017. PMID: 28868630. doi:10.1002/sim.7454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。